COVID-19ScienceVaccine Makers Turn to Microchip Tech to Beat Glass ShortagesBy Megan MolteniIdeasPeer-Reviewed Scientific Journals Don't Really Do Their JobBy Simine VazireBusinessIf Done Right, AI Could Make Policing FairerBy Will KnightCultureDoomscrolling Is Slowly Eroding Your Mental HealthBy Angela WatercutterScienceDexamethasone and the Recovery Trial’s High-Speed ScienceBy Adam RogersIdeasIt’s Ridiculous to Treat Schools Like Covid Hot ZonesBy David ZweigIdeasThe Future of Commerce Belongs to the FrictionlessBy Christiane Lemieux and Duff McDonaldIdeasCovid-19 and Living Through a New American RevolutionBy Virginia HeffernanScience5 Weird Concepts to (Theoretically) Supercharge Mask FabricsBy Vince BeiserBusinessThe President Has Suspended the Tech Industry's Favorite VisaBy Aarian MarshallCultureThere's No Cure for Covid-19 Loneliness, but Robots Can HelpBy Kate KnibbsScienceSheltering in Place Works—if You Can Afford to Stay HomeBy Gregory BarberBusinessAmazon Touts AI for Social Distancing Amid Worker ComplaintsBy Tom SimoniteScienceWhat Minnesota’s Protests Are Revealing About Covid-19 SpreadBy Megan MolteniIdeasIf the Virus Slows This Summer, It May Be Time to WorryBy Roxanne KhamsiScienceCoronavirus Researchers Are Dismantling Science's Ivory TowerBy Maimuna S. MajumderCultureAfter the Virus: How We'll Learn, Age, Move, and ListenBy WIRED StaffCultureNews at 11: Kid Reporters Tackle the CoronavirusBy Chris ColinCultureWhat Will Science, Tech, and Life Look Like After Covid-19?By WIRED StaffIdeasLive Wrong and Prosper: Covid-19 and the Future of FamiliesBy Laurie PennyBusinessHow to Make Government Trustworthy AgainBy Gideon Lewis-KrausScienceFDA Revokes Hydroxychloroquine's Emergency Use AuthorizationBy Grace HuckinsThe Big StoryScreen Share: A College Teacher’s Zoom JournalBy Anne FadimanScienceCovid-19 Is Bad. But It May Not Be the ‘Big One’By Maryn McKennaMore Stories